Header

UZH-Logo

Maintenance Infos

Total intravenous anaesthesia in horses using medetomidine and propofol


Bettschart-Wolfensberger, Regula; Kalchofner Guerrero, Karin S; Neges, K; Kästner, Sabine Beate Rita; Fürst, Anton (2005). Total intravenous anaesthesia in horses using medetomidine and propofol. Veterinary Anaesthesia and Analgesia, 32(6):348-354.

Abstract

Objective: To examine the clinical suitability of medetomidine–propofol infusions for total intravenous anaesthesia in horses.
Animals: Fifty client-owned horses of mixed breed, age [mean ± SD (range)] 6.6 ± 4.4 (0.04–18) years, mass 478 ± 168.3 (80–700) kg presented for a range of operations requiring general anaesthesia.
Materials and methods: Pre-anaesthetic medication was intravenous (IV) medetomidine 7 μg kg−1. Anaesthesia was induced with IV ketamine (2 mg kg−1) and diazepam (0.02 mg kg−1). After endotracheal intubation, O2 was delivered (FiO2 > 0.85). Positive pressure ventilation was initiated if breath-holding in excess of 1 minute occurred. Anaesthesia was maintained with a constant rate medetomidine infusion (3.5 μg kg−1 hour−1) and propofol infused IV to effect (initial dose 0.1 mg kg−1 minute−1). Heart (HR) respiratory (fr) and propofol administration rates, and systemic arterial blood pressures were recorded at 5-minute intervals. Arterial blood gas (O2 and CO2) tensions and pH values were recorded every 15 minutes. Ten minutes after ending medetomidine–propofol infusion, medetomidine (2 μg kg−1; IV) was given. Cardiopulmonary data were analysed using descriptive statistical techniques.
Results: Thirty-three orthopaedic, seven integumentary and 10 elective abdominal operations were performed. Cardiopulmonary data, presented as range of mean individual (and absolute individual minimum and maximum values) were: HR: 28.0–39.2 (16–88) beats minute−1; mean arterial blood pressure: 74.0–132.5 (42–189) mmHg; PaO2: 22.1–42.9 (4.9–67.8) kPa; [166–322 (37–508) mmHg], PaCO2: 6.7–8.1 (4.2–11.8) kPa [50–61 (32–88) mmHg] and pH 7.35–7.39 (7.15–7.48). Positive pressure ventilation was required in 23 horses. In three horses, HR values below 20 beats minute−1 were treated with 20 μg kg−1 atropine (IV). Mean propofol infusion rates were 98–108 μg kg−1 minute−1. During anaesthesia, movement occurring in 14 horses was controlled with thiopental. Duration of anaesthesia was 111.6 ± 41.4 (46–225) minutes. Recovery in all horses was uneventful and completed within 42.2 ± 19.8 (12–98) minutes.
Conclusions and clinical relevance: Medetomidine–propofol infusion produces adequate conditions for a range of surgical procedures. Cardiovascular function was adequate, as no pressor agents were required. Positive pressure ventilation was required in 23 horses.

Abstract

Objective: To examine the clinical suitability of medetomidine–propofol infusions for total intravenous anaesthesia in horses.
Animals: Fifty client-owned horses of mixed breed, age [mean ± SD (range)] 6.6 ± 4.4 (0.04–18) years, mass 478 ± 168.3 (80–700) kg presented for a range of operations requiring general anaesthesia.
Materials and methods: Pre-anaesthetic medication was intravenous (IV) medetomidine 7 μg kg−1. Anaesthesia was induced with IV ketamine (2 mg kg−1) and diazepam (0.02 mg kg−1). After endotracheal intubation, O2 was delivered (FiO2 > 0.85). Positive pressure ventilation was initiated if breath-holding in excess of 1 minute occurred. Anaesthesia was maintained with a constant rate medetomidine infusion (3.5 μg kg−1 hour−1) and propofol infused IV to effect (initial dose 0.1 mg kg−1 minute−1). Heart (HR) respiratory (fr) and propofol administration rates, and systemic arterial blood pressures were recorded at 5-minute intervals. Arterial blood gas (O2 and CO2) tensions and pH values were recorded every 15 minutes. Ten minutes after ending medetomidine–propofol infusion, medetomidine (2 μg kg−1; IV) was given. Cardiopulmonary data were analysed using descriptive statistical techniques.
Results: Thirty-three orthopaedic, seven integumentary and 10 elective abdominal operations were performed. Cardiopulmonary data, presented as range of mean individual (and absolute individual minimum and maximum values) were: HR: 28.0–39.2 (16–88) beats minute−1; mean arterial blood pressure: 74.0–132.5 (42–189) mmHg; PaO2: 22.1–42.9 (4.9–67.8) kPa; [166–322 (37–508) mmHg], PaCO2: 6.7–8.1 (4.2–11.8) kPa [50–61 (32–88) mmHg] and pH 7.35–7.39 (7.15–7.48). Positive pressure ventilation was required in 23 horses. In three horses, HR values below 20 beats minute−1 were treated with 20 μg kg−1 atropine (IV). Mean propofol infusion rates were 98–108 μg kg−1 minute−1. During anaesthesia, movement occurring in 14 horses was controlled with thiopental. Duration of anaesthesia was 111.6 ± 41.4 (46–225) minutes. Recovery in all horses was uneventful and completed within 42.2 ± 19.8 (12–98) minutes.
Conclusions and clinical relevance: Medetomidine–propofol infusion produces adequate conditions for a range of surgical procedures. Cardiovascular function was adequate, as no pressor agents were required. Positive pressure ventilation was required in 23 horses.

Statistics

Citations

Dimensions.ai Metrics
26 citations in Web of Science®
31 citations in Scopus®
52 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 06 Aug 2012
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:05 Vetsuisse Faculty > Veterinary Clinic > Equine Department
Dewey Decimal Classification:570 Life sciences; biology
630 Agriculture
Uncontrolled Keywords:Adjuvants, Anesthesia; Anesthetics, Combined; Anesthetics, Dissociative; Anesthetics, Intravenous; Animals; Blood Pressure; Diazepam; Heart Rate; Horses; Hydrogen-Ion Concentration; Hypnotics and Sedatives; Intubation, Intratracheal; Ketamine; Medetomidine; Oxygen; Partial Pressure; Propofol; Respiration; Treatment Outcome
Language:English
Date:2005
Deposited On:06 Aug 2012 07:26
Last Modified:19 Feb 2018 20:07
Publisher:Wiley-Blackwell
ISSN:1467-2987
OA Status:Closed
Publisher DOI:https://doi.org/10.1111/j.1467-2995.2005.00202.x
PubMed ID:16297044

Download

Content: Published Version
Language: English
Filetype: PDF - Registered users only
Size: 168kB
View at publisher